Asciminib, a specific allosteric BCR-ABL1 inhibitor, in patients with chronic myeloid leukemia carrying the T315I mutation in a phase 1 trial Meeting Abstract
| Authors: | Rea, D.; Lang, F.; Kim, D. W.; Cortes, J. E.; Hughes, T. P.; Minami, H.; Breccia, M.; Deangelo, D. J.; Hochhaus, A.; Talpaz, M.; Goh, Y. T.; le Coutre, P.; Deininger, M. W.; Etienne, G.; Sondhi, M.; Mishra, K.; Aimone, P.; Ng-Sikorski, J.; Mauro, M. J. |
| Abstract Title: | Asciminib, a specific allosteric BCR-ABL1 inhibitor, in patients with chronic myeloid leukemia carrying the T315I mutation in a phase 1 trial |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454837602170 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-113609 |
| Notes: | Meeting Abstract: 792 -- Source: Wos |
